SCHEMBL1406743

SCHEMBL1406743

COc1ccc2cc(C(=O)NC(=O)c3cccc(C(=O)O)c3)c(=O)oc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.67
▸ KDM4E B2RXH2 7/20 0.67
▸ HPGD P15428 7/20 0.67
▸ GAA P10253 4/20 0.67
▸ HSD17B10 Q99714 3/20 0.67
▸ GLA P06280 2/20 0.67
▸ RAB9A P51151 6/20 0.65
▸ NPC1 O15118 5/20 0.65
▸ POLB P06746 1/20 0.65
▸ SLC16A3 O15427 1/20 0.65
▸ MAPT P10636 2/20 0.63
▸ TP53 P04637 2/20 0.63
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ RXFP1 Q9HBX9 1/20 0.61
▸ MAOB P27338 5/20 0.58
▸ HTT P42858 1/20 0.55
▸ LMNA P02545 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ CA12 O43570 3/20 0.53
▸ CA2 P00918 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1406341 0.85 SLC16A3 (0.65) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL5090962 0.85 SLC16A3 (0.65) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL1406631 0.82 KDM4E (0.74) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL19338224 0.81 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL203997 0.80 SLC16A3 (1.00) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL51978 0.79 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL5087622 0.78 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL11219544 0.77 ALDH1A1 (0.81) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL20918170 0.76 ALDH1A1 (0.93) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6687148 0.76 MAOB (0.76) ALDH1A1KDM4EHPGDGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295053-B1 Novel 2H-chromen-2-one-3-carboxamides for medical uses INST MATERIA MEDICA CAMS (CN) 2016-10-19 — — EP disclosed
US-8338401-B2 Coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-12-25 — — US disclosed
EP-2295053-A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2011-03-16 — — EP disclosed
WO-2008013928-A2 TREATMENT OF CANCER WITH INTERFERON GENE DELIVERY IN COMBINATION WITH A TGF-BETA INHIBITOR BIOGEN IDEC MA INC. (US) 2008-01-31 — — WO disclosed
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2006-07-06 — — US disclosed
EP-1570846-A1 THE NOVEL COUMARIN-AMIDE DERIVATIVES AND ITS PREPARATION, SAID DRUG COMPOSITION AND ITS USE THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSR, GLS, INSRR ALDH1A1 1795/4885KDM4E 2436/4885HPGD 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback